Laurus Labs Limited — Investor Relations & Filings
Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-05 | English | |
| Copy of Newspaper Publication | 2026-05-02 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-30 | English | |
| Change in Director(s) | 2026-04-30 | English | |
| General Updates | 2026-04-30 | English | |
| General Updates | 2026-04-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42185375 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-05 | English | ||
| 42210698 | Copy of Newspaper Publication | 2026-05-02 | English | ||
| 42162636 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-30 | English | ||
| 42172534 | Change in Director(s) | 2026-04-30 | English | ||
| 42173898 | General Updates | 2026-04-30 | English | ||
| 42173954 | General Updates | 2026-04-30 | English | ||
| 42174135 | Change in Director(s) | 2026-04-30 | English | ||
| 42174169 | Record Date | 2026-04-30 | English | ||
| 42174278 | Press Release | 2026-04-30 | English | ||
| 42174348 | Investor Presentation | 2026-04-30 | English | ||
| 42174450 | General Updates | 2026-04-30 | English | ||
| 42174598 | Outcome of Board Meeting | 2026-04-30 | English | ||
| 42207909 | Reply to Clarification- Financial results | 2026-04-28 | English | ||
| 42177210 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-15 | English | ||
| 42163427 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-09 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Afexa Life Sciences Inc.
Researched, developed, and manufactured naturally derived O…
|
FXA | CA | Manufacturing |
|
AFT Pharmaceuticals Limited
Develops, licenses, and distributes pharmaceuticals across …
|
AFT | NZ | Manufacturing |
|
AFT PHARMACEUTICALS LIMITED
Develops and licenses healthcare products for pain manageme…
|
AFP | AU | Manufacturing |
|
AGENUS INC
A clinical-stage biotechnology company specializing in immu…
|
AGEN | US | Manufacturing |
|
AGIOS PHARMACEUTICALS, INC.
Biopharmaceutical company developing therapies for rare and…
|
AGIO | US | Manufacturing |
|
AHN-GOOK PHARMACEUTICAL Co., Ltd.
Develops and markets medicines, focusing on respiratory and…
|
001540 | KR | Manufacturing |
|
AIM Vaccine Co., Ltd.
Develops, manufactures, and commercializes established and …
|
6660 | HK | Manufacturing |
|
AION THERAPEUTIC INC.
Health and wellness company developing AI-driven bio-pharma…
|
AION | CA | Manufacturing |
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
Laurus Labs Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62639/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62639 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62639 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62639 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62639}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Laurus Labs Limited (id: 62639)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.